Omnicell (OMCL)
(Delayed Data from NSDQ)
$44.06 USD
-0.56 (-1.26%)
Updated Sep 23, 2024 04:00 PM ET
After-Market: $44.05 -0.01 (-0.02%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth A Momentum A VGM
Industry / Sector Report
Industry : Medical Info Systems
Zacks Industry Rank
Top 27% (67 out of 251)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.25 | 1.81 | 9.99 |
Current Quarter Estimate | 0.41 | 0.16 | 61.00 |
Year Ago Quarter Estimate | 0.62 | -0.50 | 54.84 |
Next Quarter Estimate | 0.45 | 0.36 | 63.00 |
Next Year Estimate | 1.52 | 1.25 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -26.70 | 22.30 | 15.67 |
Next Year | 8.57 | 24.10 | 11.34 |
Last 5 Years | -6.10 | -10.70 | 8.10 |
Next 5 Years | 1.40 | 18.20 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 29.95 | 21.67 |
Price/Book (MRQ) | 1.71 | 1.31 |
Price/Cash Flow (MRFY) | 14.19 | 6.83 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -1.92% | -48.54% |
Return on Equity (TTM) | 2.52% | -43.61% |
Debt to Equity (MRQ) | 0.47 | 2.90 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.